Giant Biogene Holding Co., Ltd. (HKG: 2367)

Market Cap	39.97B
Revenue (ttm)	4.79B
Net Income (ttm)	1.90B
Shares Out	1.01B
EPS (ttm)	1.93
PE Ratio	20.50
Forward PE	16.57
Dividend	0.48 (1.21%)
Ex-Dividend Date	Jun 17, 2024

Volume	2,395,023
Open	39.20
Previous Close	39.60
Day's Range	38.10 - 39.60
52-Week Range	28.75 - 54.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2024

About Giant Biogene Holding

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi’...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 1,164
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2367

Financial Performance

In 2023, Giant Biogene Holding's revenue was 3.52 billion, an increase of 49.05% compared to the previous year's 2.36 billion. Earnings were 1.45 billion, an increase of 108.59%.

Financial numbers in CNY